Ibrance 125 mg

IBRANCE 125 MG tablets are a pharmaceutical product used in cancer treatment. This medication is designed to target specific cells in the body, often used in combination with other therapies.

IBRANCE 125 MG tablets are primarily used in the treatment of certain types of cancer. This medication is often prescribed for advanced or metastatic breast cancer in combination with other treatments. It works by targeting specific proteins involved in cell division, helping to slow the growth of cancer cells. Patients should consult their healthcare provider to understand the specific uses of IBRANCE 125 MG tablets.

Common effects of IBRANCE 125 MG tablets may include fatigue, nausea, and a decrease in white blood cells. Some patients may also experience diarrhea or hair loss. These effects can vary from person to person, and not everyone will experience them. It is important to discuss any concerns with a healthcare professional.

IBRANCE 125 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should inform their doctor about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

IBRANCE 125 MG tablets may interact with certain medications, including those that affect the liver's ability to metabolize drugs. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare professional to avoid potential adverse effects.